|
Valoración de DCF de Studio City International Holdings Limited (MSC) |
Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
Predeterminadas Para Un Uso Rápido Y Eficiente
Compatible con MAC / PC, completamente desbloqueado
No Se Necesita Experiencia; Fáciles De Seguir
Studio City International Holdings Limited (MSC) Bundle
¡Valoración de Studio Studio City International Holdings Limited (MSC) utilizando nuestra calculadora DCF personalizable! Con el acceso a finanzas de MSC reales y entradas de pronóstico ajustable, puede explorar fácilmente varios escenarios y determinar el valor razonable de MSC en solo unos minutos.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 49.2 | 106.9 | 11.5 | 445.5 | 639.1 | 885.6 | 1,227.2 | 1,700.4 | 2,356.2 | 3,264.9 |
| Revenue Growth, % | 0 | 117.36 | -89.19 | 3758.14 | 43.45 | 38.57 | 38.57 | 38.57 | 38.57 | 38.57 |
| EBITDA | -141.0 | -83.9 | -141.6 | 152.8 | 202.9 | -376.3 | -521.4 | -722.5 | -1,001.1 | -1,387.1 |
| EBITDA, % | -286.72 | -78.47 | -1226.28 | 34.3 | 31.74 | -42.49 | -42.49 | -42.49 | -42.49 | -42.49 |
| Depreciation | 160.3 | 127.6 | 127.0 | 169.4 | 164.7 | 644.4 | 892.9 | 1,237.2 | 1,714.4 | 2,375.5 |
| Depreciation, % | 326.1 | 119.43 | 1099.38 | 38.02 | 25.77 | 72.76 | 72.76 | 72.76 | 72.76 | 72.76 |
| EBIT | -301.3 | -211.5 | -268.6 | -16.6 | 38.1 | -527.4 | -730.8 | -1,012.6 | -1,403.2 | -1,944.3 |
| EBIT, % | -612.82 | -197.9 | -2325.66 | -3.73 | 5.97 | -59.55 | -59.55 | -59.55 | -59.55 | -59.55 |
| Total Cash | 573.2 | 499.3 | 509.5 | 228.0 | 127.6 | 657.4 | 910.9 | 1,262.2 | 1,749.0 | 2,423.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 10.8 | 15.9 | .5 | 43.3 | 2.3 | 90.7 | 125.7 | 174.1 | 241.3 | 334.3 |
| Account Receivables, % | 22.02 | 14.92 | 4.19 | 9.71 | 0.35751 | 10.24 | 10.24 | 10.24 | 10.24 | 10.24 |
| Inventories | 9.3 | 5.8 | 5.1 | 5.8 | 7.3 | 126.0 | 174.7 | 242.0 | 335.3 | 464.7 |
| Inventories, % | 18.93 | 5.45 | 44.35 | 1.29 | 1.14 | 14.23 | 14.23 | 14.23 | 14.23 | 14.23 |
| Accounts Payable | .2 | .2 | .5 | 2.5 | 3.3 | 10.7 | 14.8 | 20.5 | 28.4 | 39.3 |
| Accounts Payable, % | 0.41898 | 0.19744 | 4.34 | 0.55079 | 0.51397 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 |
| Capital Expenditure | -188.5 | -404.5 | -452.1 | -156.8 | -86.8 | -617.8 | -856.0 | -1,186.1 | -1,643.6 | -2,277.4 |
| Capital Expenditure, % | -383.46 | -378.49 | -3915.19 | -35.2 | -13.57 | -69.75 | -69.75 | -69.75 | -69.75 | -69.75 |
| Tax Rate, % | 1.78 | 1.78 | 1.78 | 1.78 | 1.78 | 1.78 | 1.78 | 1.78 | 1.78 | 1.78 |
| EBITAT | -300.6 | -211.2 | -268.9 | -15.2 | 37.5 | -516.0 | -715.0 | -990.7 | -1,372.8 | -1,902.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -348.7 | -489.7 | -577.6 | -44.0 | 155.7 | -689.1 | -757.6 | -1,049.7 | -1,454.6 | -2,015.5 |
| WACC, % | 5.91 | 5.92 | 5.92 | 5.5 | 5.84 | 5.82 | 5.82 | 5.82 | 5.82 | 5.82 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -4,892.8 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -2,056 | |||||||||
| Terminal Value | -53,832 | |||||||||
| Present Terminal Value | -40,572 | |||||||||
| Enterprise Value | -45,465 | |||||||||
| Net Debt | 2,048 | |||||||||
| Equity Value | -47,513 | |||||||||
| Diluted Shares Outstanding, MM | 193 | |||||||||
| Equity Value Per Share | -246.71 |
What You Will Get
- Real MSC Financial Data: Pre-filled with Studio City International Holdings Limited’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See MSC’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Studio City International Holdings Limited (MSC).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to MSC.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit MSC's financial outlook.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Studio City International Holdings Limited (MSC).
- Interactive Dashboard and Charts: Visual representations that summarize essential valuation metrics for straightforward analysis.
How It Works
- Download the Template: Gain immediate access to the Excel-based MSC DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates the intrinsic value of Studio City International Holdings Limited (MSC).
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis decisions.
Why Choose This Calculator for Studio City International Holdings Limited (MSC)?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters effortlessly to suit your financial analysis.
- Real-Time Valuation: Observe immediate updates to MSC's valuation as you modify inputs.
- Preloaded Data: Comes with Studio City’s actual financial metrics for swift evaluations.
- Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Investors: Assess the intrinsic value of Studio City International Holdings Limited (MSC) to inform investment choices.
- CFOs: Utilize a high-quality DCF model for accurate financial reporting and analysis.
- Consultants: Easily customize the template for client valuation reports related to (MSC).
- Entrepreneurs: Discover financial modeling techniques employed by leading companies, including (MSC).
- Educators: Implement it as a resource for teaching valuation methods in finance courses.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations for Studio City International Holdings Limited (MSC).
- Real-World Data: Historical and projected financials for Studio City International Holdings Limited (MSC) preloaded for in-depth analysis.
- Customizable Parameters: Tailor WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into Studio City International Holdings Limited (MSC).
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to Studio City International Holdings Limited (MSC).
- Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results related to Studio City International Holdings Limited (MSC).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.